MAP7D1 anticorps (N-Term)
Aperçu rapide pour MAP7D1 anticorps (N-Term) (ABIN632935)
Antigène
Voir toutes MAP7D1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- MAP7 D1 antibody was raised against the N terminal of MAP7 1
-
Purification
- Affinity purified
-
Immunogène
- MAP7 D1 antibody was raised using the N terminal of MAP7 1 corresponding to a region with amino acids RRRLEEQRLKAEQRRAALEERQRQKLEKNKERYEAAIQRSVKKTWAEIRQ
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
MAP7D1 Blocking Peptide, (ABIN5614659), is also available for use as a blocking control in assays to test for specificity of this MAP7D1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of MAP0 1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- MAP7D1 (MAP7 Domain Containing 1 (MAP7D1))
-
Autre désignation
- MAP7D1
-
Sujet
- The function of MAP7 protein is not widely studied, and is yet to be elucidated fully.
-
Poids moléculaire
- 93 kDa (MW of target protein)
-
Pathways
- SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2
Antigène
-